An alternative measure of health for value assessment: the equal value life-year

PharmacoEconomics

10 September 2023 - The quality-adjusted life-year (QALY) is an international standard in cost-effectiveness analysis. A known concern arises from the relatively lower QALY gains attributed to treatments that extend the life of individuals with chronic disability. 

We analyze here the advantages and disadvantages of the equal value life-year (evLY) as an alternative or a complementary measure to the QALY, and share learned experiences from using this measure in health technology assessments.

Read PharmacoEconomics press release

Michael Wonder

Posted by:

Michael Wonder